KromaTiD Appoints Nathan Wood as Chief Executive Officer
By: Colorado BioScience Association Date: 08/16/2021
KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the for...
Learn MoreFitzsimons Innovation Community Accelerates Growth
By: Colorado BioScience Association Date: 08/12/2021
Breaks ground on first full-scale commercial manufacturing facility, for cell and gene therapy AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its new bioscie...
Learn MoreTerumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
By: Colorado BioScience Association Date: 08/11/2021
Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood component collection, therapeutic apheresis and cellula...
Learn MoreAGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
By: Colorado BioScience Association Date: 08/06/2021
AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of a state-of-the-art commercial manufacturing...
Learn MoreBoulder iQ Names Larry Blankenship as Director, Helping Life Sciences Companies with Product Development
By: Colorado BioScience Association Date: 08/05/2021
Boulder iQ has named Larry Blankenship director. Blankenship is a veteran medical device industry professional, with more than 30 years of experience in product development, manufacturing, regulatory...
Learn MoreCSU Receives $2 Million Grant to Help Prevent Future Pandemics
By: Colorado BioScience Association Date: 07/28/2021
Building on its response to the COVID-19 pandemic, Colorado State University has received a $2 million commitment from The Anschutz Foundation to further the development of new solutions for building...
Learn MoreEvergreen Research Appoints New President, Natasha Bond
By: Colorado BioScience Association Date: 07/28/2021
Evergreen Research, Inc. (Evergreen), a leading provider of contract development, manufacturing, and regulatory/quality assurance services, is pleased to announce the appointment of Natasha (Tasha) Bo...
Learn MoreNasal-Spray Combined Vaccine for Covid and Flu Shows Protection
By: Colorado BioScience Association Date: 07/27/2021
Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratorydiseases, today announced positive preclinical data supporting fu...
Learn MoreOutlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer
By: Colorado BioScience Association Date: 07/27/2021
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, t...
Learn MoreLightDeck Diagnostics Appoints Nick Traggis as CEO to Scale Company Operations Through Next Phase of Growth
By: Colorado BioScience Association Date: 07/21/2021
LightDeck Diagnostics today announced that Nick Traggis has transitioned from executive vice president of Corporate Development to Chief Executive Officer (CEO). Chris Myatt, who precedes M...
Learn More